BioAmber announces closing of IPO

By Erin Voegele | May 21, 2013

BioAmber Inc. has announced the closing of its initial public offering (IPO) of 8 million units, each consisting of one share of common stock and one warrant to purchase half of one share of common stock at $10 per unit. According to information released by the company, each warrant will be exercisable at an exercise price of $11 per whole share of common stock.

The units are listed on the New York Stock exchange under the symbol BIOA.U. The company also intends to list its common stock on the Professional Segment of the regulated market of MYSE Euronext in Paris under the symbol BIOA.

BioAmber originally filed a registration form for the IPO with the U.S. Securities and Exchange Commission in November 2011. Pricing for the IPO was announced in early May. Credit Suisse, Barclays and Société Générale acted as joint book-running managers for the offering. Pacific Crest Securities acted as co-manager for the offering.